Literature DB >> 9794908

Fibrosis accelerates the development of enzyme-altered lesions in the rat liver.

I Sakaida1, K Hironaka, K Uchida, C Suzuki, K Kayano, K Okita.   

Abstract

Injection of pig serum into rats twice a week for 8 weeks induced stellate cell activation resulting in liver fibrosis without parenchymal cell injury. Administration of a choline deficient L-amino acid defined (CDAA) diet for 6 weeks with or without pig serum pretreatment led to the development of preneoplastic lesions that were positive for the placental form of glutathione S-transferase (GSTP). Pig serum pretreatment induced more activated stellate cells in the livers of rats subsequently fed a CDAA diet for 6 weeks compared with rats fed the CDAA diet alone. Activated stellate cells were detected as smooth muscle actin (SMA)-positive cells and by the expression of SMA messenger RNA. These cells caused severe fibrosis as assessed by the hepatic hydroxyproline content. Pre-existing fibrosis induced by the activation of stellate cells with pig serum pretreatment increased hepatic malondialdehyde (MDA) level in parallel with GSTP-positive lesions. These results indicate that pre-existing fibrosis with the activated stellate cells accelerates the development of preneoplastic lesions in a CDAA diet model.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794908     DOI: 10.1002/hep.510280512

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis.

Authors:  Haiyan Jin; Shuji Terai; Isao Sakaida
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

2.  Adeno-associated virus mediated interferon-gamma inhibits the progression of hepatic fibrosis in vitro and in vivo.

Authors:  Miao Chen; Guang-Ji Wang; Yong Diao; Rui-An Xu; Hai-Tang Xie; Xin-Yan Li; Jian-Guo Sun
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

3.  Antifibrotic effect of MMP13-encoding plasmid DNA delivered using polyethylenimine shielded with hyaluronic acid.

Authors:  Eun-Joong Kim; Hee-Jeong Cho; Daeui Park; Ji Yeon Kim; Young Bong Kim; Tae Gwan Park; Chang-Koo Shim; Yu-Kyoung Oh
Journal:  Mol Ther       Date:  2010-12-07       Impact factor: 11.454

4.  Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosis.

Authors:  Issei Saeki; Shuji Terai; Koichi Fujisawa; Taro Takami; Naoki Yamamoto; Toshihiko Matsumoto; Yoshikazu Hirose; Yasuhiko Murata; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2012-09-26       Impact factor: 7.527

5.  Inhibitory effect of antisense oligonucleotide targeting TIMP-2 on immune-induced liver fibrosis.

Authors:  Qing-He Nie; Chuan-Long Zhu; Ya-Fei Zhang; Jie Yang; Jiu-Cong Zhang; Ren-Tao Gao
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

6.  Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.

Authors:  Yosui Tamaki; Yukiomi Nakade; Taeko Yamauchi; Yuichi Makino; Shiro Yokohama; Mitsuyoshi Okada; Kazunobu Aso; Hiroyuki Kanamori; Tomohiko Ohashi; Ken Sato; Haruhisa Nakao; Masakazu Haneda; Masashi Yoneda
Journal:  J Gastroenterol       Date:  2012-08-14       Impact factor: 7.527

7.  Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis.

Authors:  Hitoshi Yoshiji; Ryuichi Noguchi; Tadashi Namisaki; Kei Moriya; Mitsuteru Kitade; Yosuke Aihara; Akitoshi Douhara; Hideto Kawaratani; Norihisa Nishimura; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2013-11-07       Impact factor: 7.527

8.  Early induction of TGF-beta1 through a fasting-re-feeding regimen promotes liver carcinogenesis by a sub-initiating dose of diethylnitrosamine.

Authors:  L Tessitore; E Bollito
Journal:  Cell Prolif       Date:  2006-04       Impact factor: 6.831

9.  Fibrosis and inflammatory activity in noncancerous tissue and mitotic index of cancer tissue in patients with hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.

Authors:  Atsushi Nanashima; Kenji Tanaka; Hiroyuki Yamaguchi; Shinichi Shibasaki; Shigeyuki Morino; Megumi Yoshinaga; Terumitsu Sawai; Tohru Nakagoe; Hiroyoshi Ayabe
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

10.  Blockage of transforming growth factor beta receptors prevents progression of pig serum-induced rat liver fibrosis.

Authors:  Wei Jiang; Chang-Qing Yang; Wen-Bin Liu; Yi-Qing Wang; Bo-Ming He; Ji-Yao Wang
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.